A call to action on pharmacovigilance; New Rosetta modeling protocols for computational biologists;

> An international group from academia and the private and public sectors has hammered the Minimum Information about a Bioactive Entity (MIABE) data standard for describing the effect of a drug on a biological target. Release

> An op-ed piece in The Scientist argues that, while governments have advanced pharmacovigilance programs, much work needs to be done to monitor the safety drugs distributed around the world. Opinion piece

> PLoS One has made the RosettaCon 2010 available to provide researchers with open access to some of the latest macromolecular modeling protocols. Blog post

> Outsourcing-Pharma has rounded up some new product-related announcements from such EDC providers as BioClinica, Max Neeman, Clinovo, StudyManager and DZS Software Solutions. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.